文献速递神经康复

可穿戴踝关节机器人用于亚急性卒中阶梯与平地步行训练:随机对照试验

Effects of wearable ankle robotics for stair and over-ground training on sub-acute stroke: a randomized controlled trial.
PubMed 文献 · J Neuroeng Rehabil · 2021-01-29

这项两中心随机对照试验纳入卒中后2个月内的亚急性期患者,比较常规训练联合20次可穿戴踝机器人(PAAR或SCAR)阶梯与平地训练与单纯常规训练。结果显示三组均有组内功能改善,SCAR组功能性步行分类改善优于对照组,PAAR组步行速度改善优于SCAR组。

要点

  • SCAR组功能性步行分类改善优于单纯常规训练组(均差+0.6,中等效应量0.610)。
  • PAAR组步行速度改善优于SCAR组(均差+0.15 m/s,大效应量0.752)。
  • 三组在20次干预后所有结局指标均显示组内统计学显著且临床有意义的改善(p<0.005)。

核心结论

  • 机器人辅助阶梯训练在步行独立性与步行速度方面较常规训练带来更大功能改善。
  • 主动动力踝辅助可能帮助用户在阶梯和平地步行时以患腿走得更快更多。

研究设计与样本

  • 两中心随机对照试验,纳入卒中后2个月内的亚急性期卒中幸存者。
  • PAAR组n=14,SCAR组n=16,常规训练对照组n=17;机器人辅助训练共20次,至少每周两次,每次30分钟,在平地与阶梯环境进行。
  • 主要结局为功能性步行分类,同时评估Berg平衡量表和10米步行计时测试;干预前后进行临床评估。

主要发现

  • 20次干预后,三组在所有结局指标上均显示组内统计学显著且临床有意义的改善(p<0.005)。
  • 组间比较显示SCAR组功能性步行分类改善更大(均差+0.6,中等效应量0.610)。
  • SCAR组训练后独立步行者超过56%,而对照组仅为29%。
  • 协方差分析显示PAAR组步行速度改善优于SCAR组(均差+0.15 m/s,大效应量0.752)。
  • PAAR组步行速度优势与20次机器人辅助平地及阶梯训练中穿戴机器人时更高的步频和速度一致。

关键数值与推荐

  • 可穿戴踝机器人重量为0.5 kg,为轻便型便携式外骨骼。
  • PAAR为动力辅助踝机器人,主动协助患侧踝运动以增强残余运动功能。
  • SCAR为摆动控制踝机器人,通过锁定/释放踝关节在摆动相被动支撑足下垂以促进足廓清。
  • 亚急性期定义为卒中发病后2个月内。
  • 机器人辅助训练方案为20次、至少每周两次、每次30分钟。

临床怎么用

  • 对卒中后2个月内的亚急性期患者,可在常规训练基础上联合可穿戴踝机器人进行平地与阶梯步行训练。
  • 以改善步行独立性为主要目标时,可考虑使用SCAR进行阶梯与平地训练。
  • 以改善步行速度为主要目标时,可考虑使用PAAR进行阶梯与平地训练。

局限性

  • 原文未报告盲法、分配隐藏、脱落或不良事件等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Wearable ankle robotics could potentially facilitate intensive repetitive task-specific gait training on stair environment for stroke rehabilitation. A lightweight (0.5 kg) and portable exoskeleton ankle robot was designed to facilitate over-ground and stair training either providing active assistance to move paretic ankle augmenting residual motor function (power-assisted ankle robot, PAAR), or passively support dropped foot by lock/release ankle joint for foot clearance in swing phase (swing-controlled ankle robot, SCAR). In this two-center randomized controlled trial, we hypothesized that conventional training integrated with robot-assisted gait training using either PAAR or SCAR in stair environment are more effective to enhance gait recovery and promote independency in early stroke, than conventional training alone. METHODS: Sub-acute stroke survivors (within 2 months after stroke onset) received conventional training integrated with 20-session robot-assisted training (at least twice weekly, 30-min per session) on over-ground and stair environments, wearing PAAR (n = 14) or SCAR (n = 16), as compared to control group receiving conventional training only (CT, n = 17). Clinical assessments were performed before and after the 20-session intervention, including functional ambulatory category as primary outcome measure, along with Berg balance scale and timed 10-m walk test. RESULTS: After the 20-session interventions, all three groups showed statistically significant and clinically meaningful within-group functional improvement in all outcome measures (p < 0.005). Between-group comparison showed SCAR had greater improvement in functional ambulatory category (mean difference + 0.6, medium effect size 0.610) with more than 56% independent walkers after training, as compared to only 29% for CT. Analysis of covariance results showed PAAR had greater improvement in walking speed than SCAR (mean difference + 0.15 m/s, large effect size 0.752), which was in line with the higher cadence and speed when wearing the robot during the 20-session robot-assisted training over-ground and on stairs. CONCLUSIONS: Robot-assisted stair training would lead to greater functional improvement in gait independency and walking speed than conventional training in usual care. The active powered ankle assistance might facilitate users to walk more and faster with their paretic leg during stair and over-ground walking. TRIAL REGISTRATION: ClinicalTrials.gov NCT03184259. Registered on 12 June 2017.

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Yeung LF, Lau CCY, Lai CWK, et al. Effects of wearable ankle robotics for stair and over-ground training on sub-acute stroke: a randomized controlled trial. J Neuroeng Rehabil. 2021. PMID: 33514393. doi:10.1186/s12984-021-00814-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。